Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2008;12(3):153.
doi: 10.1186/cc6899. Epub 2008 May 29.

Progesterone in traumatic brain injury: time to move on to phase III trials

Marianne Vandromme  1 , Sherry M Melton, Jeffrey D Kerby
Affiliations
Comment

Progesterone in traumatic brain injury: time to move on to phase III trials

Marianne Vandromme et al. Crit Care. 2008.

Abstract

There are several candidate neuroprotective agents that have been shown in preclinical testing to improve outcomes following traumatic brain injury (TBI). Xiao and colleagues have performed an in hospital, double blind, randomized, controlled clinical trial utilizing progesterone in the treatment of patients sustaining TBI evaluating safety and long term clinical outcomes. These data, combined with the results of the previously published ProTECT trial, show progesterone to be safe and potentially efficacious in the treatment of TBI. Larger phase III trials will be necessary to verify results prior to clinical implementation. Clinical trials networks devoted to the study of TBI are vital to the timely clinical testing of these candidate agents and need to be supported.

PubMed Disclaimer

Comment on

References

    1. Xiao G, Wei J, Yan W, Wang W, Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care. 2008;12:R61. doi: 10.1186/cc6887. - DOI - PMC - PubMed
    1. Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, Salomone JP, Dent LL, Harris OA, Ander DS, Lowery DW, Patel MM, Denson DD, Gordon AB, Wald MM, Gupta S, Hoffman SW, Stein DG. ProTect: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med. 2007;49:391–402. doi: 10.1016/j.annemergmed.2006.07.932. - DOI - PubMed
    1. Stein DG, Wright DW, Kellerman AL. Does progesterone have neuroprotective properties? Ann Emerg Med. 2008;51:164–172. doi: 10.1016/j.annemergmed.2007.05.001. - DOI - PubMed
    1. Schouten JW. Neuroprotection in traumatic brain injury: a complex struggle against the nature of biology. Curr Opin Crit Care. 2007;13:134–142. doi: 10.1097/MCC.0b013e3280895d5c. - DOI - PubMed
    1. Wang KK, Larner SF, Robinson G, Hayes RL. Neuroprotection targets after traumatic brain injury. Curr Opin Neurol. 2006;19:514–519. doi: 10.1097/WCO.0b013e3280102b10. - DOI - PubMed

MeSH terms

LinkOut - more resources